BURROUGHS WELLCOME’s MEPRON (ATOVAQUONE) IS A SECOND-LINE THERAPY FOR MILD TO MODERATE PCP IN PATIENTS "INTOLERANT" TO TMP/SMX, ADVISORY CMTE. CONCURS